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Abstract
Cohort studies are the analytical design of observational studies that are epidemiologi-
cally used to identify and quantify the relationship between exposure and outcome. Due 
to the longitudinal design, cohort studies have several advantages over other types of 
observational studies. The purpose of this chapter is to cover the various characteristics of 
prospective cohort studies. This chapter is divided into three main sections. In the first we 
introduce the concept and ranking of cohort studies, as well as the advantages and dis-
advantages. In the second we focus on the design of cohort studies, mainly its prospec-
tive aspect, and the distinguishing features from the retrospective type. The section also 
covers the essential characteristics of a cohort study design and its varied applications in 
medical research. In the third we go over examples of prospective studies in the medical 
field. For each, an overview of the study design is given, along with a random selection 
of study findings/impact, strengths and weaknesses.
Keywords: observational study, cohort study, prospective cohort study, longitudinal 
study, study design, epidemiology, medical research
1. Cohort studies
1.1. Introduction
The term “cohort” originates from Latin “cohors” [1]. A term that was used in the military 
back in Roman times, which referred to a unit that is comprised of 300–600 men, of which 
each 10 cohorts were named a legion [2]. In the field of epidemiology, Frost was the first to 
introduce the term “cohort study” back in 1935 [3]. Cohort refers to a group of individuals 
that share a common factor or a defining characteristic [4, 5], or in other words, cohort is a 
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certain component of a specific population that can be measured and followed throughout 
time [6]. Cohort studies are classified under the non-experimental type of studies [4], which 
are observational by default [7].
A cohort study follows people as groups, two or more, from exposure to outcome [2, 8]. The 
two groups would be categorized based on their exposure status to “exposed” and “unex-
posed” [4, 9, 10]. If there were multiple groups then these would be categorized either by 
the type or level of exposure [4]. The main characteristic of a cohort study is that it follows 
participants in a forward manner, from the presence of the exposure to the presence of the 
outcome [2, 9–11]. Or as De Rango describes it: using a longitudinal pattern, a cohort study, 
follows a group or groups of individuals over time in order to ascertain the incidence of a 
predetermined outcome after being exposed to a certain factor, whether being a risk factor, 
medication, or intervention [12]. Cohort studies can either be prospective (concurrent) or ret-
rospective (non-concurrent) [9].
1.2. Ranking of cohort studies
Researchers agree that cohort studies, as related to the hierarchy of evidence, rank below 
meta-analysis, systematic review and randomized controlled trial, but rank higher than case–
control studies, cross sectional studies, case series/reports [13–16]. As newer models or clas-
sifications of the hierarchy of evidence have emerged, where meta-analysis and systematic 
reviews have been removed from the hierarchy and repositioned as a magnifying glass or 
a lens through which evidence from other types of studies can be viewed or scrutinized; 
cohort studies remain below randomized controlled trials and higher than the other types 
[17]. Cohort studies provide information on the relationship between exposure and outcome 
when a randomized controlled trial is not possible to conduct for whatever reason [6, 15].
1.3. Advantages of cohort studies
Cohort studies are the design of choice when randomization is not practical or ethical [6, 18]. 
They are also useful in the study of infections [9] and for hypothesis generation [19]. Due to 
the design of cohort studies, and since temporal sequence is present, both incidence rate and 
cumulative incidence can be calculated [2, 8, 20–22]. They also allow for the measurement of 
relative risk (RR) [2, 8, 23], hazard ratio [8], and attributable risk [8, 23]. Furthermore, they allow 
for the study of multiple outcomes that can be associated with a single type of exposure [2, 20] 
or multiple exposures [18]. Additionally, they allow for the study of rare exposures [2, 18, 20]. 
Finally, cohort studies have lower risk of encountering survivor bias [2], and recall bias [9, 21]. 
Survivor bias occurs when focusing only on those who survived or made it through a certain 
criteria or point, and ignoring those that didn’t, such as studying rapidly fatal diseases [2].
1.4. Disadvantages of cohort studies
Among the disadvantages of cohort studies is selection bias, which may occur when the par-
ticipants are not representative of the population or of the patient grouping that they fall 
under. This in turn will influence how well or not the results can be generalized to the rest of 
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the population, in what is known as external validity [2, 12, 18, 24, 25]. This will be covered 
later in section three of this chapter under aspects of cohort studies. Another disadvantage 
is that causation cannot be established from cohort studies [18, 20], as it would require an 
experimental design in order to determine any causal effect [20]. However, due to the longi-
tudinal design of cohort studies, they may aid in studying a certain causal hypothesis [20]. A 
third disadvantage is that they require a large sample size, which might pose an issue when 
dealing with outcomes that take a long time to develop [10]. Finally, cohort studies cannot be 
used to study rare outcomes [23].
2. Prospective cohort studies
2.1. Types of cohort studies
Cohort studies are either prospective or retrospective [1, 2, 18]. In the former, the researcher 
would assess exposure at baseline and then follow the person over time in order to determine 
the outcome such as the development of a disease [9, 18, 20, 21, 26]. In the latter, the order is 
reversed, as a cohort is established after the follow up has been conducted, or the outcome has 
developed, and exposure is then assessed in a retrospective manner [9, 18, 20, 21, 27]. Merrill 
indicates that the outcome status at the start of the study is what determines the overall study 
type. If the outcome has not yet developed then it is a prospective study, and if the outcome 
has already developed then it is a retrospective study [23]. Cohort studies can also be classi-
fied based on whether or not participants are replaced once they are lost. If those that drop 
out or are lost to follow up are replaced with new participants, then this would be classified 
as a dynamic or an open cohort. In the case that those lost do not get replaced, then it would 
be classified as a fixed or closed cohort [4, 20].
2.1.1. Prospective cohort studies
Prospective cohort studies, as the name indicates, observes a group of people after being 
exposed to a certain factor in order to investigate the outcome, following the natural sequence 
of time, starting with the present and looking forward in time [12, 18, 20], which in turn pro-
vides true risk (absolute) estimates for the groups under investigation [26]. It is considered 
the gold standard among observational studies [8]. Under this type of study, the researcher 
would have control over data collection methodology, as well as the overall cohort study set 
up, which gives prospective cohort studies an advantage over retrospective cohort studies 
[9]. Further advantages and disadvantages of prospective cohort studies are discussed below.
2.1.1.1. Advantages of prospective cohort studies
Euser et al. highlight the major advantage of prospective cohort studies as being accurate 
in regards to the information collected about exposures, endpoints, and confounders [18]. 
Others list the following as advantages of prospective cohort studies; first: the exposure has 
already been measured before the outcome has occurred, which allows for the assessment of 
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temporal sequence [28]. This allows for the calculation of incidence and the determination of 
the disease process [2, 12, 20, 23]. Second: elimination of recall bias, as there is no need for 
any recollection of information since the data is being collected in a prospective manner [7]. 
However, Kip et al. reported that recall bias can pose an issue in prospective cohort studies if 
the exposure is self-reported, brief, and requires multiple measurements, such as stress epi-
sodes [29]. Third: It allows for the study of exposures were randomization is not practical or 
ethical [12]. Fourth: it allows for the study of rare exposures [20]. Fifth: it allows for the study 
of multiple outcomes [20, 26].
2.1.1.2. Disadvantages of prospective cohort studies
Among the disadvantages of prospective cohort studies is the loss to follow up, which is com-
mon among cohort studies. This can ultimately lead to differential loss to follow up among 
those exposed and unexposed, which in turn can complicate the interpretation of the results 
[2, 7, 12, 18, 24]. Another disadvantage is that they are time consuming if follow up periods are 
far apart. This would be resource consuming as well, which would make prospective cohort 
studies not suitable for the study of outcomes that take long time to develop [18, 20, 24, 26]. A 
third disadvantage is that they are expensive to conduct [18, 20, 30]. The third section of this 
chapter is dedicated to providing examples of prospective cohort studies.
2.1.2. Retrospective cohort studies
As previously described, retrospective cohort studies, also known as historic [28] or historical 
[24] cohorts, use data that has already been collected, such as databases of healthcare records, 
in order to investigate the association between the exposure and the outcome [22, 24, 26, 
28]. Although the outcome has already occurred, the design of retrospective cohort studies 
is similar to those of prospective cohort studies [22]. They also have similar advantages and 
disadvantages [26, 28]. Hess indicates that retrospective studies in general are useful as pilot 
studies for future prospective studies [31].
Retrospective cohort studies have advantages and disadvantages. They are time efficient and 
cheap since the data has been collected previously and is available for scrutiny [18, 20, 26]. 
Additionally, since the exposure has already been measured before the outcome has occurred, 
this allows for the assessment of temporal sequence [28]. However, retrospective cohort stud-
ies use information that has been collected in the past for another objective other than the 
current study [18], and in some cases, collected for a purpose that is not related to medical 
research [9]. Due to this factor, the investigator lacks control over the collection of data [24, 26, 
27]. Additionally, the measurement of exposure and outcome might be inconsistent or inac-
curate, which can become a source of bias [24, 27, 28, 31, 32].
Examples of retrospective cohort studies:
High plasma phosphate as a risk factor for decline in renal function and mortality in 
pre-dialysis patients [18, 33]. In this study, Voormolen et al. followed the clinical course 
among incident pre-dialysis patients, using medical charts, to study the decline in kid-
ney function and its association with plasma phosphate levels [18, 33].
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Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide 
retrospective cohort study [28, 34]. In this study, Friberg et al. investigated gender dif-
ferences in the incidence of stroke among those with atrial fibrillation using the Swedish 
hospital discharge registry [28, 34].
Outcomes of care by hospitalists, general Internists, and family physicians [35]. In this 
study, Lindenauer et al. collected data from various hospitals in the USA, and compared 
the outcome of patients treated by the three types of care provider [35].
2.1.3. Aspects of cohort studies
2.1.3.1. Validity
Validity is the epidemiological assessment to the lack of systematic error [4, 11]. There are 
two types of validity: internal validity and external validity [4, 11, 25]. Internal validity refers 
to the inferences made from the study that are related to the same source population [4, 5, 11, 
25, 36], as to whether or not the study has measured what it had originally planned on mea-
suring [25, 36]. For an example, if the exposure caused the observed change in the outcome, 
then the study would be considered to have high internal validity [11]. On the other hand, if 
the observed change in the outcome was caused by a systematic error (bias), then the study 
would be considered to have low internal validity [11]. Threats or violations to internal valid-
ity will be discussed later in this section under bias.
External validity refers to the degree to which the study results can be generalized to other 
populations [4, 5, 11, 25, 36]. For example, if the study participants were not representative 
of the general population, then the study results cannot be generalizable to others [12]. The 
highest level of external validity occurs when the results can be generalized to three other 
domains: other populations, other environments, and other times [36]. External validity can 
be improved by using random selection [37].
It is essential to have internal validity in order to establish external validity; that is the study 
must have internal validity in the first place in order to have external validity [4, 11]. For an 
example, if the exposure caused the observed change in the outcome, then the results can 
be generalizable to others. If the observed change was caused by any other factor, then the 
results cannot be generalized to others [4, 11]. Based on the validity hierarchy, cohort studies 
are considered to have low internal validity, while the external validity is high [11, 16].
2.1.3.2. Bias
Bias is a study systematic error in the design, conduct, or analysis that can be categorized into 
three main categories: selection bias, information bias, and confounding [4, 25, 38]. Selection 
bias occurs when the sample chosen for the study is not obtained randomly, so that the sample 
chosen is no longer representative of the overall population [4, 25, 38, 39]. This type of bias 
includes three types: attrition bias, non-respondent bias, and the healthy entrant effect [38]. 
Attrition bias, or loss to follow up bias, occurs due to dropouts or death, which can be encoun-
tered in studies with long follow up durations (prospective) [23]. Non-respondent bias occurs 
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when those that respond are different than those that don’t respond. For example, nonsmok-
ers are more likely to return questionnaires about smoking than smokers are [25]. The healthy 
entrant effect or the healthy worker effect occurs when there are differences between those 
that are exposed and those that are not exposed. For an example, when comparing working 
individuals to the general population, as workers are more likely to be healthier than the 
general population. In order to avoid this type of bias, it is recommended to use two similar 
groups, such as using two groups of working individuals [23].
Information bias (measurement bias) [25], occurs when the data obtained is being recorded 
inaccurately [4, 25, 38–40]. This type of bias can be differential (nonrandom) or nondiffer-
ential (random) as related to the outcome [4, 9, 23, 25]. The former is dependent on other 
variables and leads to overestimation or underestimation of any possible association, while 
the latter is independent from other variables and leads to underestimation of any pos-
sible association [4, 9, 23], and if the exposure was dichotomous, this type leads to bias 
towards the null [9]. Non differential is more commonly encountered in cohort studies [9]. 
Information bias can be reduced by using standardized assessment tools that have been 
validated [9]. Information bias is also known as classification bias, observation bias [25], or 
misclassification bias [23].
Confounding: confounding is a distortion of the effect [4, 25] that may lead to overestimation 
or underestimation of an effect, or even reversing the direction of an effect [4]. A confound-
ing factor is a risk factor that is associated with the exposure and influences the outcome, 
however, is not related to the causation sequence [4, 25, 39]. Unlike selection and information 
bias, confounding can be controlled for prior to study initiation, or after study completion 
[25]. Controlling for confounding factors can be accomplished through: restriction, matching, 
stratification, and using multivariate techniques [23, 25, 27].
Restriction would involve excluding those with the confounding factor [23, 25]. If the con-
founding factor is categorical, then participants that fall within that category would be 
excluded [4], such as if smoking was considered to be a confounding factor, then those that 
smoke would be excluded [25]. If the confounding factor was continuous, such as age, then a 
range of that variable would be used to restrict the confounding [4]. Matching would involve 
choosing two groups that are similar to each other as much as possible [23, 25, 41], such as 
matching by gender or age [39]. Matching can be either individual matching or frequency 
matching. The former involves matching on an individual participant level, while the latter 
refers to matching on a group level [4]. Overmatching may occur when matching is being 
used, which may reflect on the statistical efficiency, validity, or cost efficiency of the study [4]. 
After the completion of the study, and during the analysis stage, stratification can be used to 
control for confounding by dividing the groups into several subgroups that are based on the 
confounding factor [23, 25, 39, 41]. Multivariate techniques are also used during the analysis 
stage and allow for the control of multiple factors [25, 39, 41].
2.1.3.3. Exposure and risk
Exposure must be determined using a clear and accurate definition [2, 22], which in some 
cases may involve levels of exposure [2]. This helps in eliminating possible selection bias 
[2]. The challenge becomes greater when there are multiple exposure assessments over an 
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extended period of time [30]. The validity and the cost are two important aspects that must be 
taken into consideration when selecting an exposure measurement tool [30].
Both groups, those exposed and those that are not exposed should be at risk of eventually 
developing the outcome at some stage [2]. The exclusion criteria should exclude those that 
are not at risk of developing the outcome [24]. For an example, a study investigating the role 
of antipsychotics in the development of diabetes, should exclude those with diabetes to start 
with, since they are not at risk [10]. This helps in eliminating possible selection bias [2].
2.1.3.4. Outcomes
Outcomes should have a clear and specific definition from the beginning of the study [2, 22], 
which must be measurable as well [2, 22]. Outcomes should also be measured in a similar 
manner across all participants [2, 22]. This helps in eliminating possible information bias [2]. 
It is recommended to use measurement tools that have been previously validated when deal-
ing with secondary data, and to blind those who are assessing the outcome when dealing with 
primary data [10].
2.1.3.5. Controls
The comparison group or controls (unexposed group) should be similar to the exposed group 
in all possible aspects, but differ in regards to the exposure itself [2]. Three types of controls 
can be used, with the first being the most preferable: internal comparisons, other external 
cohorts, and the general population [2].
2.1.3.6. Follow up
To avoid loss to follow up and its consequent effects on the validity of the study results; mea-
sures should be taken in order to minimize the attrition rate [2, 22, 24, 27, 42]. Some of these 
actions include excluding those that are at high risk of not committing to the study, providing 
incentives for participation, collecting personal information that would allow or facilitate future 
contact, and maintaining ongoing contact on regular basis during the conduction period of the 
study [2, 23, 24, 27]. The maximum acceptable limit for loss to follow up is 20% [23, 24, 42].
2.1.3.7. Precision
Precision is based on the absence of random error or chance [4, 11]. This random variation can 
be due to the sample itself, or how it was selected, or how it was measured [4, 11]. Standard 
deviations and confidence intervals are useful in determining the precision of a study, as a large 
standard deviation or a wide confidence interval would indicate low precision [11]. Random 
error or variation can be reduced by increasing the sample size [4, 27, 43], improving how you 
sample and how you measure, in addition to using the appropriate statistical methods [43].
2.1.3.8. Analysis of data
The main statistical term or product of cohort studies is the relative risk or risk ratio [6, 21], 
which represents the risk of developing the outcome among those that are exposed in relation 
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to those that are not exposed [20]. An RR that is equivalent to 1 indicates an absence of any 
type of association. An RR that is greater than 1 would indicate that there is a positive cor-
relation between the exposure and risk of developing a disease. An RR that is smaller than 
1 would indicate the presence of a protective effect between the exposure and the outcome 
[12]. Other outcome measures include: hazard ratios, survival curves, and life-table rates [2]. 
Some of the common statistical analysis involving cohort studies include: analysis of variance 
(ANOVA), multivariate analysis of variance (MANOVA), mixed effect regression model, and 
generalized estimating equation models [7].
2.1.3.9. Reporting
The reporting of prospective cohort studies should follow the STROBE guidelines [12], which 
also apply to other observational studies [41, 44]. This acronym stands for: Strengthening the 
Reporting of Observational Studies in Epidemiology. These guidelines were designed by a 
group of international scholars including journal editors, epidemiologists, statisticians and 
researchers in order to set universal standards when reporting observational studies. It is com-
prised of a 22 item checklist that precisely dictates what should be reported under each section 
of an article [44–47]. Sessler and Imrey indicate that the most crucial ones are related to the 
study: objectives, methodology, definitions, source of data, statistical analysis, participants, 
and results [41]. Further information can be found at http://www.strobe-statement.org/.
Bookwala et al. outlined three main factors that aid in evaluating prospective cohort stud-
ies in their article titled “the three-minute appraisal of a prospective cohort study”. These 
are related to (1) comparison groups selection; (2) the impact of confounding variables; (3) 
type of analytical strategy used [48]. Finally, the equator network (which is supported by 
the University of Oxford, UK, and aims to improve the quality and transparency of health 
research) provides guidelines and instructions for the reporting of various kinds of studies. 
These can be found at www.equator-network.org. Additional information regarding what to 
look for in a cohort study, as well as evaluation checklists can be found elsewhere [2, 8, 11, 25, 
39, 48, 49]. The next section of this chapter will cover examples of famous prospective cohort 
studies from the medical field.
3. Examples of prospective cohort studies
3.1. The Framingham Heart Study
3.1.1. Overview
The Framingham heart study, initiated in 1948 by The National Heart Institute (currently 
the National Heart, Lung, and Blood Institute) [50], is considered to be the longest, ongoing, 
prospective cohort study in the history of the USA [51]. Others view it as a live model that 
illustrates the cohort design [52]. The study was based on the hypothesis that arteriosclerosis 
and hypertensive cardiovascular disease are the result of several causation factors combined 
rather than an individual factor [53]. Based on this, the aim of the study was to investigate 
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the factors that contribute to the development of cardiovascular disease (CVD) by following 
a large cohort of individuals over a long period of time [50]. Back then in 1951, when the first 
article about the study was published, little was known about arteriosclerosis and hyperten-
sive cardiovascular disease [53].
The original cohort included 5209 participants, ages 30–62 years, that were recruited at the 
beginning of the study in the town of Framingham, Massachusetts, USA [50]. The same cohort 
has been followed since initiation every two years for physical, laboratory, and lifestyle exam-
inations [50]. The second generation, the offspring cohort, was recruited in 1971 and included 
5124 participants. While 1994 witnessed the enrollment of the first Omni cohort (n = 506), in 
order to diversify the study population. More recently in 2002, the third generation cohort 
(n = 4095) was enrolled, while in 2003 the new offspring cohort (n = 103), and the second Omni 
group (n = 410) was enrolled [50]. The study continues to follow these cohorts every 2–6 years 
[54]. This multi generation, multi ethnicity, enrollment design aided significantly in the study 
of genetics in relation to a wide range of factors and illnesses [51, 54].
Based on the Framingham study data, since initiation and through November 2017, a 
total of 3561 articles have been published so far [55]. The accumulation of knowledge that 
has risen from this study has shed the light on cardiovascular disease risk factors [50, 
51, 56], by further expanding on our understanding of chronic illnesses such as diabetes, 
obesity, metabolic syndrome and nonalcoholic fatty liver disease [51, 57]. Such risk fac-
tors include high blood pressure, high cholesterol levels, smoking, obesity, diabetes, and 
physical inactivity [50, 57].
The study was the basis of which the Framingham risk score was built on [56]. Initially pub-
lished by Wilson et al. in 1998 [58], it allows for the calculation of a 10 year risk estimate of 
developing coronary heart disease (CHD) based on the levels of different variables [56, 58]. 
This would allow for the undertaking of preventive measures [56]. Later on in 2002, the Adult 
Treatment Panel of the National Cholesterol Education Program used the risk score as a foun-
dation for its risk calculator [56].
3.1.2. Study findings
The study website (https://www.framinghamheartstudy.org/about-fhs/research-milestones.
php) covers a long list of findings, among those; cigarette smoking was discovered to increase 
ones risk of developing heart disease back in 1960. In 1970, high blood pressure was discov-
ered to increase ones risk of stroke. In 1988, the beneficial effects of HDL cholesterol were 
discovered. In 2002, the study found that obesity is considered a risk factor leading to heart 
failure. More recently in 2010 sleep apnea was linked to a higher risk of stroke [59]. More 
information and a full list of research milestones can be found elsewhere [59].
3.1.3. Strengths and weaknesses
In addition to what had been previously discussed regarding the benefits of the prospec-
tive design of the study, a high retention rate is among the strengths of the Framingham 
Heart Study as participants continue to return for their follow up visits despite the years [54]. 
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Among the weaknesses is that the study was conducted in one population residing in one 
locality [7], which in turn reflects on the ability to generalize findings to other populations [58]. 
Another weakness is that the study cohort was not randomly selected, as investigators had to 
use volunteers in order to obtain the necessary sample. The final cohort ended up being more 
healthy when compared to the general population [7, 60].
3.2. The Nurses’ Health Study (NHS)
3.2.1. Overview
This National Institutes of Health (NIH) funded study started in 1976 [61], and as of today 
includes more than 275,000 participants and counting, as the Nurses’ Health Study 3 is still 
recruiting subjects [62]. The study looks into the risk factors that have been implicated in 
major chronic diseases among women [62]. Initially, the study focused on heart disease, can-
cer, smoking, and contraceptive methods [61]. As the study evolved, it investigated many 
other lifestyle factors, characteristics, and diseases [61, 63].
The original cohort of the study has been followed up on by mail every two years, with 
a minimum response rate of 90% [61]. The second cohort, under NHS 2, was enrolled in 
1989 and included 116,430 women. These also were followed up on using mail every two 
years. A food frequency questionnaire was added in 1991 and was mailed out every four 
years, with a response rate of 85–90%. Later on blood and urine samples were collected 
from participants [61]. The third cohort, under NHS 3, was enrolled in 2010 and is still 
enrolling, with a goal of diversifying the study population to include other ethnic back-
grounds [61].
3.2.2. Study findings
The study website (http://www.nurseshealthstudy.org/about-nhs/key-contributions-scien-
tific-knowledge) covers numerous study findings, such as reporting lower risk of colon can-
cer and polyps with higher levels of vitamin D [64]. Also among the findings, Giovannucci 
et al. reported lower risk rates of colon cancer with longer duration of aspirin usage [65]. 
Baer et al. reported on mortality related risk factors among the NHS cohort [66]. Other find-
ings related to breast cancer, CHD, stroke, colon cancer, hip fracture, cognitive function, and 
eye disease, in relation to cigarette smoking, oral contraceptives, post-menopausal hormone 
therapy obesity, alcohol, and diet can be found elsewhere [64, 67–79]. More recently Colditz 
et al. summarized the findings and impact of the three NHS studies in an article published in 
the American Journal of Public Health [80].
3.2.3. Strengths and weaknesses
With focus on women, it is considered to be the longest and largest running prospective cohort 
study that investigates the role of lifestyle on health [63]. Among the strengths of this study is 
that it included multiple assessments of the various lifestyle characteristics and exposure fac-
tors [63, 80], in turn, it also contributed to the methodology of lifestyle assessment in general, 
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which has been used in other studies [63, 80]. Additionally, it allowed for the calculation of 
mortality rates [63]. As for the weaknesses, white women dominated the original cohort, which 
reflects on the generalizability of the study results [4, 63].
3.3. The Caerphilly Prospective Study (CAPS)
3.3.1. Overview
Also known as the Caerphilly Heart Disease Study, this study was conducted in Caerphilly, 
South Wales, UK, and focused on ischemic heart disease (IHD) in relation to hormones, hemo-
static factors, and lipids [81]. As the study evolved, other investigations were included which 
looked into cognitive function, stroke and hearing problems [81].
The study included four phases. In the first phase, 2512 males, ages 45–59 years, were 
recruited in 1979. The procedures included blood tests, electrocardiogram (ECG), clinical his-
tory, lifestyle and IHD related questionnaires [81]. The second phase ran from 1984 to 1988 
and included 447 males. An audiometry test was added to the list of investigations that were 
included in the first phase [81]. Phase 3 took place from 1989 to 1993 and added a cognitive 
function test and a bleeding time test [81]. Phase 4 was conducted from 1993 to 1997, which 
included the audiometry and cognitive function tests originally included in the second and 
third phases, respectively [81]. Follow up was conducted at a later stage through mail. The 
study has accumulated in a total of 150 studies and counting [81].
3.3.2. Study findings
Among the findings of the Caerphilly Prospective study; Elwood et al. showed that adopting 
a healthy lifestyle was associated with lower rates of chronic disease, as well as less cognitive 
impairment and dementia [82]. In other findings, Mertens et al. reported an inverse associa-
tion between CVD and adopting a healthy diet [83], while Bolton et al. reported an inverse 
association between mid-life lung function and arterial stiffness among men [84]. Additional 
findings can be found elsewhere [85–91].
3.4. Conclusion
The three sections of this chapter covered the two types of cohort studies. Observational stud-
ies in general and cohort studies in specific are a good source of information when an experi-
ment is not feasible. Prospective cohort studies provide valuable information when studying 
the relationship between exposure and outcome. As with any type of study, prospective 
cohort studies come with advantages and disadvantages that need to be taken into consider-
ation when interpreting the results of these studies.
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